2018 RESEARCH
- Archives -Michael Green and Allan Jacobson elected to American Academy of Arts and Sciences
Two distinguished scientists from UMass Medical School—Michael Green, MD, PhD, and Allan Jacobson, PhD—have been elected to the American Academy of Arts and Sciences Class of 2018. They join a group of 213 individuals elected this year that includes Barack Obama and 2018 UMMS Commencement speaker Huda Y. Zoghbi, MD.
In Pincus Lecture, Patricia Donahoe details pioneering work in reproductive endocrinology
Renowned pediatrician and cancer researcher Patricia Donahoe, MD, is the recipient of the 2018 Gregory Pincus Medal from UMass Medical School. She delivered the Pincus Memorial Lecture at UMMS on April 11.
At MassBiologics, Heidi Smith works to move innovative therapies from bench to bedside
As senior director of clinical affairs at MassBiologics of UMass Medical School, Heidi Smith, MD, PhD, is focused on developing products that address unmet medical needs and diseases of public health concern. Learn more in this Women in Science video.
UMass Medical School awards Patricia Donahoe 2018 Pincus Medal
Renowned pediatrician and cancer researcher Patricia Donahoe, MD, has been named the 2018 recipient of the Gregory Pincus Medal by UMass Medical School. She will deliver the Pincus Memorial Lecture at UMMS on April 11.
Scientists explore how novel diet eases inflammatory bowel disease
Inflammatory bowel disease patients are taking part in a pilot clinical trial underway at UMass Medical School to examine how diet may relieve symptoms. Researchers are seeking to better understand how the anti-inflammatory diet works by altering the bacteria which populate the intestinal microbiome.
Chancellor Collins, faculty attend biomedical research conference in China
Chancellor Michael F. Collins and several members of the UMass Medical School faculty joined former Secretary of State John F. Kerry for the 2018 Shenzhen Life and Health Sciences Conference in Shenzhen, China.
UMass Medical School HIV vaccine to be tested in new Phase I trial
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest by UMass Medical School’s Shan Lu, MD, PhD, to harness the power of DNA vaccines.
Discovery of new ALS gene points to common role of cytoskeleton in disease
An international team of researchers co-led by John Landers, PhD, has identified KIF5A as a new gene associated with the development of amyotrophic lateral sclerosis. The discovery, published in the journal Neuron, advances the understanding of what causes ALS and further implicates the role of cytoskeletal defects in the axon as a common factor in the disease.
Fungal infections re-emerge with surge in opioid crisis, study shows
UMass Medical School researchers have identified a re-emergence in fungal infections associated with cases of illicit intravenous drug use in Massachusetts as opioid overdoses continue to soar, according to Stuart Levitz, MD.
UMass Medical School ranked among nation’s finest for primary care
The annual U.S. News & World Report rankings of the best graduate schools names UMass Medical School in the top 10 percent nationwide in primary care, coming in 14th among 144 medical schools and 33 schools of osteopathic medicine surveyed by the weekly news magazine in its 2019 edition of the “Best Graduate Schools.”
